Back

The efficacy of tolvaptan in acute heart failure - an updated meta-analysis

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Acute Heart Failure Pharmacotherapy HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Kristel Tanhui

St. Luke's Medical Center, Quezon (Philippines)

21 More presentations in this session

Presentation thumbnail
Treatment of cardiogenic shock complicating peripartum cardiomyopathy with the calcium sensitizer, levosimendan - data from the german PPCM registry
Doctor T. Pfeffer (Hannover, DE)
Abstract
Presentation thumbnail
The effect of levosimendan on the short-term outcome of cardiopulmonary bypass surgery in cardiomyopathic patients
Presentation thumbnail
Levosimendan alone or combined with inotropes in an acute heart failure unit
Doctor B. Rocha (Lisbon, PT)
Abstract
Presentation thumbnail
Effects of levosimendan in patients with chagas cardiomyopathy hospitalized for acute heart failure
Doctor G. Perez Cortes (Ciudad de Mexico, MX)
Abstract
Presentation thumbnail
A formula to calculate discharge furosemide dose after an acute heart failure hospitalization
Associate Professor P. Bettencourt (Porto, PT)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Acute Heart Failure

The Event

Event poster

Heart Failure 2019

25 May - 28 May 2019
You may be interested in
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Congress Presentation
Early hospital management
thumbnail
Congress Presentation
Acute and advanced heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources